Quality assessment programs for dietary supplements

被引:17
作者
Larimore, WL
O'Mathúna, DP
机构
[1] Focus Family, Colorado Springs, CO 80920 USA
[2] Univ Colorado, Dept Family Med, Denver, CO 80202 USA
[3] Mt Carmel Coll Nursing, Columbus, OH USA
关键词
certification; dietary supplement; quality assurance; quality control;
D O I
10.1345/aph.1D031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: In the US, consumers and healthcare professionals have been forced to depend on self-regulation by the dietary supplement industry for product quality, consistency, potency, and purity, a system that has yielded mixed results at best. OBJECTIVE: To characterize the current state of product quality verification in the dietary supplement industry and review recent developments and future plans to improve supplement safety and regulation. METHODS: Studies describing the quality of dietary supplements are reviewed, along with recent Food and Drug Administration (FDA) plans to improve supplement regulation. Several independent dietary supplement quality certification programs are described and evaluated. RESULTS: Quality control standards for dietary supplements run the gamut from good to nonexistent. Contamination, false labeling, and incomplete labeling are not uncommon problems - as are significant discrepancies in disintegration, dissolution, and in vitro release characteristics of various dietary supplements. The need for improved regulation has led to plans for increased FDA involvement through enforcement of good manufacturing practices and truths in labeling. Meanwhile, independent product certification companies have emerged and provide some reassurances; however, they possess several limitations as well. CONCLUSIONS: Until proposed FDA initiatives are finalized and implemented, certification programs can help provide assurances of safety and assist in product selection. Although they do not testify to effectiveness (and may even inadvertently mislead some consumers), certification programs may help curb what has been called "the Wild West nature of the dietary supplement industry".
引用
收藏
页码:893 / 898
页数:6
相关论文
共 40 条
[1]  
BENT S, 2003, ANN INTERN MED
[2]   Pharmacological activity of feverfew (Tanacetum parthenium (L) Schultz-Bip): Assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro [J].
Brown, AMG ;
Edwards, CM ;
Davey, MR ;
Power, JB ;
Lowe, KC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (05) :558-561
[3]  
Bunten W, 1999, J Am Pharm Assoc (Wash), V39, P14
[4]   Challenges and opportunities confronting the botanical dietary supplement industry [J].
Cardellina, JH .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (07) :1073-1084
[5]   WHAT DO COMMERCIAL GINSENG PREPARATIONS CONTAIN [J].
CUI, J ;
GARLE, M ;
ENEROTH, P ;
BJORKHEM, I .
LANCET, 1994, 344 (8915) :134-134
[6]   Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng [J].
Cui, JF ;
Garle, M ;
Bjorkhem, I ;
Eneroth, P .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (02) :151-160
[7]  
*FDA, 2002, FDA PRESS RELEA 1218
[8]   Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease [J].
Feifer, AH ;
Fleshner, NE ;
Klotz, L .
JOURNAL OF UROLOGY, 2002, 168 (01) :150-154
[9]  
*FOOD NUTR BOARD B, 2002, PROP FRAM EV SAF DIE
[10]   Content versus label claims in ephedra-containing dietary supplements [J].
Gurley, BJ ;
Gardner, SF ;
Hubbard, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (10) :963-969